MALLORY NEAL: Open Payments
NPI 1255902821 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 63 payments from 18 companies in 2025. Trend: 2023 $1,320 · 2024 $1,652 · 2025 $1,607
Food & beverage: $1,607
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $280 |
| Alnylam Pharmaceuticals Inc. | 7 | $242 |
| United Therapeutics Corporation | 5 | $235 |
| ABIOMED | 7 | $202 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $112 |
| Novo Nordisk Inc | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Actelion Pharmaceuticals US, Inc. | 2 | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $46 |
Products named: WINREVAIR, AMVUTTRA, VERQUVO, Tyvaso, Adempas, ONPATTRO, WAINUA, CAMZYOS.
Industry payments across OK — which companies pay providers there.
